Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 6,971 across all filing types
Latest filing 2026-04-27 Legal Proceedings Report
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
TESARO update on AnaptysBio Inc. litigation
Legal Proceedings Report Classification · 92% confidence The document is an RNS announcement by GSK providing an update on ongoing litigation between its subsidiary TESARO and AnaptysBio. It discusses a court decision dismissing one claim, details of the licensing dispute, and forward‐looking statements. This clearly falls under a legal proceedings update rather than a financial report, earnings release, or M&A notice. Therefore, it is classified as a Legal Proceedings Report (LTR).
2026-04-27 English
6-K - GSK plc (0001131399) (Filer)
Foreign Filer Report
2026-04-24 English
Director/PDMR Shareholding
Director's Dealing Classification · 95% confidence The document is an RNS transaction notification filed by a Person Discharging Managerial Responsibilities (PDMR) detailing an acquisition of American Depositary Shares by a senior executive. This is a personal share transaction by a company director/executive, fitting the ‘Director’s Dealing’ category.
2026-04-24 English
6-K - GSK plc (0001131399) (Filer)
Foreign Filer Report
2026-04-23 English
Transaction in Own Shares
Transaction in Own Shares Classification · 98% confidence The document is an RNS notice from GSK plc titled "Transaction in own shares" and details the company’s share buyback programme, including aggregate and individual trade data, treasury holdings, and voting rights percentages. This clearly corresponds to a share repurchase transaction rather than an earnings release, dividend notice, or management report. Therefore, it matches the “Transaction in Own Shares” category.
2026-04-23 English
6-K - GSK plc (0001131399) (Filer)
Foreign Filer Report
2026-04-22 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.